Casi pharmaceuticals announces second quarter 2023 business and financial updates

Beijing , aug. 11, 2023 /prnewswire/ -- casi pharmaceuticals, inc. (nasdaq: casi), a biopharmaceutical company focused on developing and commercializing innovative therapeutics and pharmaceutical products, today reported financial results for the quarter ended june 30, 2023.  wei-wu he, ph.d.
CASI Ratings Summary
CASI Quant Ranking